Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
Zachary C. Dobbin(University of Alabama at Birmingham), Charles N. Landen(University of Alabama at Birmingham)
Cited by 119
Related Papers
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
|Clinical Cancer Research|2011|368